Importantly, a longitudinal study (4–10 years) enrolling AD and VaD patients revealed higher MMP-9 levels in the CSF of VaD patients compared to AD or controls (Adair et al., 2004). The gene discussed is MMP9; the disease is Alzheimer disease.